Insider · CIK 0001543779
Michael Gunnar Knell
officer
Files at CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 30, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | AGrant or award Common Stock | +2,064 | $135.63 | $280k | 10,807 | Jun 3, 2025 |
| May 31, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | FTax withholding Common Stock | -48 | $135.63 | $6,510 | 10,759 | Jun 3, 2025 |
| Jun 1, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | FTax withholding Common Stock | -225 | $135.63 | $31k | 10,534 | Jun 3, 2025 |
| May 26, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | FTax withholding Common Stock | -50 | $136.73 | $6,837 | 8,805 | May 29, 2025 |
| May 27, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | FTax withholding Common Stock | -37 | $136.73 | $5,059 | 8,768 | May 29, 2025 |
| May 28, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | FTax withholding Common Stock | -25 | $138.65 | $3,466 | 8,743 | May 29, 2025 |
| Jan 31, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | AGrant or award Common Stock | +811 | $0.00 | $0 | 9,137 | Feb 3, 2025 |
| Jan 31, 2025 | CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | FTax withholding Common Stock | -282 | $165.57 | $47k | 8,855 | Feb 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.